Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational polypharmacy in schizophrenia

O M Wolkowitz1

  • 1Langley Porter Psychiatric Institute, University of California, San Francisco Medical Center 94143.

Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veterans.

Translational psychiatry·2017
Same author

Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal study.

Molecular psychiatry·2017
Same author

Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.

Translational psychiatry·2016
Same author

Peripheral telomere length and hippocampal volume in adolescents with major depressive disorder.

Translational psychiatry·2015
Same author

Telomere length and cortisol reactivity in children of depressed mothers.

Molecular psychiatry·2014
Same author

Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study.

Molecular psychiatry·2013
Same journal

Factors Associated With Severe Mental Illnesses Newly Diagnosed in Perinatal Psychiatric Care: Findings From a Large Clinical Cohort.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2026
Same journal

Protest behaviors among patients placed in seclusion in a psychiatric emergency service.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Problematic internet use and suicidal behavior in adolescents: A review.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Development of a mobile monitoring program for anxiety and depression in pregnancy and evaluation of 3-month results.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Vitamin D levels among adult psychiatric inpatients and the association with psychosis.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
Same journal

Same but different? Phenomenological differences among various types of body-focused repetitive behaviors.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2023
See all related articles

For schizophrenia patients unresponsive to standard neuroleptics, adjunctive treatments like lithium and electroconvulsive therapy show promise. Individualized treatment selection is key, as no single therapy benefits all patients with treatment-resistant schizophrenia.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Schizophrenia treatment often involves neuroleptics, but 10-30% of patients exhibit poor response.
  • Identifying effective augmentation strategies for treatment-resistant schizophrenia is a significant clinical challenge.

Purpose of the Study:

  • To review adjunctive treatments for schizophrenia patients with poor neuroleptic response.
  • To outline an evaluative and treatment approach for this patient population.

Main Methods:

  • Literature review of studies on augmenting neuroleptic effects in schizophrenia.
  • Analysis of clinical characteristics to guide treatment selection.

Main Results:

  • Lithium, benzodiazepines, carbamazepine, reserpine, and electroconvulsive therapy demonstrate the most evidence for efficacy.

Related Experiment Videos

  • Other agents like propranolol, clonidine, valproic acid, and L-dopa may benefit individual patients.
  • Antidepressants can address comorbid depression in non-psychotic patients.

    • Conclusions:

    • No single adjunctive treatment is universally effective; response rates vary significantly.
    • Personalized treatment selection based on individual patient characteristics is crucial.
    • Exploring differential responses to biochemically distinct agents may reveal schizophrenia subgroups.